These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 21816304)

  • 21. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction.
    Corpus RA; House JA; Marso SP; Grantham JA; Huber KC; Laster SB; Johnson WL; Daniels WC; Barth CW; Giorgi LV; Rutherford BD
    Am Heart J; 2004 Sep; 148(3):493-500. PubMed ID: 15389238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Jensen LO; Thayssen P; Farkas DK; Hougaard M; Terkelsen CJ; Tilsted HH; Maeng M; Junker A; Lassen JF; Horváth-Puhó E; Sørensen HT; Thuesen L
    EuroIntervention; 2012 Aug; 8(4):456-64. PubMed ID: 22917729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry).
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Am J Cardiol; 2012 Apr; 109(7):941-6. PubMed ID: 22236463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Lansky AJ; Ng VG; Meller S; Xu K; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
    JACC Cardiovasc Interv; 2014 Mar; 7(3):266-75. PubMed ID: 24650400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization.
    Mylotte D; Morice MC; Eltchaninoff H; Garot J; Louvard Y; Lefèvre T; Garot P
    JACC Cardiovasc Interv; 2013 Feb; 6(2):115-25. PubMed ID: 23352816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment elevation myocardial infarction and multivessel disease.
    Zhang D; Song X; Lv S; Yuan F; Xu F; Zhang M; Li W; Yan S
    PLoS One; 2014; 9(3):e92316. PubMed ID: 24651489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.
    Ntalianis A; Sels JW; Davidavicius G; Tanaka N; Muller O; Trana C; Barbato E; Hamilos M; Mangiacapra F; Heyndrickx GR; Wijns W; Pijls NH; De Bruyne B
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1274-81. PubMed ID: 21232721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Culprit only versus complete coronary revascularization during primary PCI.
    Qarawani D; Nahir M; Abboud M; Hazanov Y; Hasin Y
    Int J Cardiol; 2008 Jan; 123(3):288-92. PubMed ID: 17428557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.
    Tang J; Chu J; Hou H; Lai Y; Tu S; Chen F; Yao Y; Ye Z; Gao Y; Mao Y; Zhuang S; Liu X
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):755-766. PubMed ID: 33044717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
    Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
    Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock.
    Cavender MA; Rajeswaran J; DiPaola L; Houghtaling P; Kiernan MS; Rassi AN; Menon V; Whitlow PW; Ellis SG; Shishehbor MH
    J Invasive Cardiol; 2013 May; 25(5):218-24. PubMed ID: 23645045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Wang TY; McCoy LA; Bhatt DL; Rao SV; Roe MT; Resnic FS; Cavender MA; Messenger JC; Peterson ED
    Am Heart J; 2016 Feb; 172():9-18. PubMed ID: 26856210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bainey KR; Mehta SR; Lai T; Welsh RC
    Am Heart J; 2014 Jan; 167(1):1-14.e2. PubMed ID: 24332136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Lekston A; Tajstra M; Gąsior M; Gierlotka M; Pres D; Hudzik B; Trzeciak P; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2011; 69(4):336-43. PubMed ID: 21523666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Song YJ; Shin HC; Yang JI; Lee HY; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Jang JS
    J Interv Cardiol; 2015 Feb; 28(1):1-13. PubMed ID: 25689544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete versus culprit-only revascularization during primary percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Lu C; Huang H; Li J; Zhao J; Zhang Q; Zeng Z; Chen Y
    Kaohsiung J Med Sci; 2013 Mar; 29(3):140-9. PubMed ID: 23465417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Terkelsen CJ; Horváth-Puhó E; Tilsted HH; Maeng M; Junker A; Lassen JF; Thuesen L; Sørensen HT; Thayssen P
    Am Heart J; 2015 Jul; 170(1):70-8. PubMed ID: 26093866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.